Jubilant Pharmova: No Share Transfer Requests Processed in Special Window as of Dec 31

Jubilant Pharmova Limited has provided an update regarding the special window for re-lodgement of transfer requests for physical shares, as per SEBI Circular No. SEBI/HO/MIRS D/MIRSD-PoD/P/CIR/2025/97...

Jubilant Pharmova Limited has provided an update regarding the special window for re-lodgement of transfer requests for physical shares, as per SEBI Circular No. SEBI/HO/MIRS D/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025. As of December 31, 2025, the company's Registrar and Share Transfer Agent, Alankit Assignments Limited, has reported that there were no requests received, processed, approved, or rejected during the month. Consequently, the average time taken for processing requests was nil. This information is also available on the company's website, www.jubilantpharmova.com. The company has submitted this report to the BSE Limited and the National Stock Exchange of India Limited for their records.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Jubilant Pharmova Limited in the news today?

Jubilant Pharmova Limited (JUBLPHARMA) is in the news due to the announcement is a routine update on share transfer requests, with no positive or negative financial or operational developments to report.

Share Transfer UpdatesOther Regulatory Filings
Jubilant Pharmova LimitedJUBLPHARMAhttps://prysm.fi/v2/analyze/JUBLPHARMA

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Jubilant Pharmova: No Share Transfer Requests Processed in Special Window as of Dec 31

January 2, 2026, 12:48 PM

AI Sentiment Analysis

Top Queries to Ask About Jubilant Pharmova Limited

More Details on This News

Jubilant Pharmova Limited has provided an update regarding the special window for re-lodgement of transfer requests for physical shares, as per SEBI Circular No. SEBI/HO/MIRS D/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025.

As of December 31, 2025, the company's Registrar and Share Transfer Agent, Alankit Assignments Limited, has reported that there were no requests received, processed, approved, or rejected during the month. Consequently, the average time taken for processing requests was nil.

This information is also available on the company's website, www.jubilantpharmova.com. The company has submitted this report to the BSE Limited and the National Stock Exchange of India Limited for their records.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Jubilant Pharmova Limited

Discover more trending news on Prysm

View All